A novel apoptosis pathway activated by the carboxyl terminus of p21

Chen Dong1, Qing Li, Shu-Chen Lyu

  • 1Division of Immunology and Transplantation Biology, Department of Pediatrics, CCSR 2105, 300 Pasteur Dr, Stanford University, Stanford, CA 94305-5164, USA.

Blood
|October 7, 2004
PubMed

Insights

A novel peptide, p21-IRS, induces apoptosis in lymphoid cells via a unique mitochondrial pathway. This discovery offers potential for new cancer therapies targeting aberrant cells.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • The protein p21 regulates cell cycle progression and has diverse cellular functions.
  • p21 interacts with various proteins including cyclins, cyclin-dependent kinases, and proliferating cell nuclear antigen (PCNA).
  • Delivery of active peptides into cells is crucial for studying intracellular processes and developing therapeutics.

Purpose of the Study:

  • To investigate the molecular mechanisms of apoptosis induced by the chimeric peptide p21-IRS.
  • To determine if p21-IRS activates a known or novel apoptotic pathway.
  • To explore the therapeutic potential of p21-IRS for eliminating aberrant cells.

Main Methods:

  • Synthesis of a chimeric peptide, p21-IRS, comprising the p21 carboxyl terminus and a cell-penetrating pentapeptide (RYIRS).
  • Treatment of lymphoid cells with p21-IRS and comparison with other proapoptotic agents.
  • Analysis of molecular events during p21-IRS-induced apoptosis, focusing on mitochondrial involvement, caspases, and mitochondrial membrane potential (Deltapsi(m)).

Main Results:

  • The p21-IRS peptide rapidly enters lymphoid cells and effectively activates apoptosis.
  • p21-IRS triggers a novel apoptotic pathway distinct from those activated by conventional proapoptotic agents.
  • Mitochondria play a central role in p21-IRS-induced apoptosis, but caspases and a decrease in Deltapsi(m) are not involved.

Conclusions:

  • p21-IRS activates a unique, caspase- and Deltapsi(m)-independent apoptotic pathway centered on mitochondria.
  • Targeting specific cell populations with p21-IRS holds promise for developing innovative therapies against human diseases characterized by aberrant cell proliferation.
  • Further research into this novel pathway could reveal new therapeutic strategies.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.